Amalgamated Financial’s Labcorp LH Stock Holding History

Amalgamated Financial’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$6.33M	Buy	+27,957	New	+$6.57M	0.05%	348

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Amalgamated Financial's LH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Labcorp (LH) in Q1 2022: 27,957 shares worth $6.33M. The stake represents 0.05% of the portfolio and ranks #348 among its holdings.

1,034 funds tracked by Wall St. Rank hold LH as of Q1 2022.

Amalgamated Financial held 27,957 shares of Labcorp worth $6.33M as of Q1 2022.
Labcorp was a new Amalgamated Financial position in Q1 2022.
Labcorp made up 0.05% of Amalgamated Financial's portfolio in Q1 2022, its #348 holding.
1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.